SELLAS Life Sciences's top three insider shareholders as of May 04, 2026 are Angelos M. Stergiou (President And Ceo, 686.97K shares), Dragan Cicic (Svp, Chief Development Officer, 557.80K shares), John Thomas Burns (Cfo, 554.33K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Angelos M. Stergiou | President And Ceo | 686,966 | 0 | 05 Dec, 2025 |
| Dragan Cicic | Svp, Chief Development Officer | 557,805 | 0 | 09 Jan, 2026 |
| John Thomas Burns | Cfo | 554,327 | 0 | 09 Jan, 2026 |
| Angelos M. Stergiou | President And Ceo | 217,421 | 0 | 08 Dec, 2023 |
| Katherine Bach Kalin | - | 154,400 | 0 | 09 Jan, 2026 |
| Barbara A Wood | Evp, Gen. Counsel, Corp. Sec. | 117,225 | 0 | 24 Jan, 2024 |
| Jane Wasman | - | 92,900 | 0 | 09 Jan, 2026 |
| Barbara A Wood | Evp, Gen. Counsel, Corp. Sec. | 82,225 | 0 | 08 Dec, 2023 |
| David A Scheinberg | - | 73,082 | 0 | 09 Jan, 2026 |
| John Thomas Burns | Cfo | 54,927 | 0 | 08 Dec, 2023 |
| Robert Francomano | Chief Commercial Officer | 40,918 | 0 | 24 Jan, 2024 |
| Robert Francomano | Chief Commercial Officer | 20,918 | 0 | 08 Dec, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Jan, 2026 | David A Scheinberg | Common Stock | A | 50,000 | $0.00 | 73,082 | D | A |
| 07 Jan, 2026 | Katherine Bach Kalin | Common Stock | A | 50,000 | $0.00 | 154,400 | D | A |
| 07 Jan, 2026 | John Thomas Burns | Common Stock | A | 300,000 | $0.00 | 554,327 | D | A |
| 07 Jan, 2026 | Dragan Cicic | Common Stock | A | 300,000 | $0.00 | 557,805 | D | A |
| 07 Jan, 2026 | Jane Wasman | Common Stock | A | 50,000 | $0.00 | 92,900 | D | A |
| 03 Dec, 2025 | Angelos M. Stergiou | Common Stock | D | 187,066 | $1.50 | 686,966 | D | J |
| 03 Dec, 2025 | John Thomas Burns | Common Stock | D | 58,592 | $1.50 | 254,327 | D | J |
| 03 Dec, 2025 | Dragan Cicic | Common Stock | D | 63,800 | $1.50 | 257,805 | D | J |
| 19 Nov, 2025 | Katherine Bach Kalin | Common Stock | A | 63,400 | $1.59 | 104,400 | D | P |
| 30 May, 2025 | Jane Wasman | Common Stock | A | 20,000 | $1.69 | 30,400 | D | P |
| 22 May, 2025 | Katherine Bach Kalin | Common Stock | A | 20,000 | $1.80 | 41,000 | D | P |
| 10 Jan, 2025 | Jane Wasman | Common Stock | A | 12,500 | $0.00 | 22,900 | D | A |
| 10 Jan, 2025 | Katherine Bach Kalin | Common Stock | A | 12,500 | $0.00 | 21,000 | D | A |
| 10 Jan, 2025 | John Thomas Burns | Common Stock | A | 113,000 | $0.00 | 217,762 | D | A |
| 10 Jan, 2025 | Angelos M. Stergiou | Common Stock | A | 257,000 | $0.00 | 615,132 | D | A |
| 10 Jan, 2025 | Dragan Cicic | Common Stock | A | 113,000 | $0.00 | 228,328 | D | A |
| 10 Jan, 2025 | David A Scheinberg | Common Stock | A | 12,500 | $0.00 | 23,082 | D | A |
| 10 Jan, 2025 | David A Scheinberg | Stock Option (Right to Buy) | A | 18,500 | $0.00 | 18,500 | D | A |
| 10 Jan, 2025 | Jane Wasman | Stock Option (Right to Buy) | A | 18,500 | $0.00 | 18,500 | D | A |
| 10 Jan, 2025 | Dragan Cicic | Common Stock | A | 81,300 | $0.00 | 309,628 | D | A |